Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 78

1.

HIV-1 full-genome phylogenetics of generalized epidemics in sub-Saharan Africa: impact of missing nucleotide characters in next-generation sequences.

Ratmann O, Wymant C, Colijn C, Danaviah S, Essex M, Frost SDW, Gall A, Gaiseitsiwe S, Grabowski M, Gray R, Guindon S, von Haeseler A, Kaleebu P, Kendall M, Kozlov A, Manasa J, Minh BQ, Moyo S, Novitsky V, Nsubuga R, Pillay S, Quinn TC, Serwadda D, Ssemwanga D, Stamatakis A, Trifinopoulos J, Wawer M, Leigh Brown A, de Oliveira T, Kellam P, Pillay D, Fraser C.

AIDS Res Hum Retroviruses. 2017 May 25. doi: 10.1089/AID.2017.0061. [Epub ahead of print]

PMID:
28540766
2.

Quantifying predictors for the spatial diffusion of avian influenza virus in China.

Lu L, Leigh Brown AJ, Lycett SJ.

BMC Evol Biol. 2017 Jan 13;17(1):16. doi: 10.1186/s12862-016-0845-3.

3.

Phylogenetic Tools for Generalized HIV-1 Epidemics: Findings from the PANGEA-HIV Methods Comparison.

Ratmann O, Hodcroft EB, Pickles M, Cori A, Hall M, Lycett S, Colijn C, Dearlove B, Didelot X, Frost S, Hossain AS, Joy JB, Kendall M, Kühnert D, Leventhal GE, Liang R, Plazzotta G, Poon AF, Rasmussen DA, Stadler T, Volz E, Weis C, Leigh Brown AJ, Fraser C; PANGEA-HIV Consortium..

Mol Biol Evol. 2017 Jan;34(1):185-203. doi: 10.1093/molbev/msw217. Epub 2016 Oct 7.

PMID:
28053012
4.

HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK.

El Bouzidi K, White E, Mbisa JL, Sabin CA, Phillips AN, Mackie N, Pozniak AL, Tostevin A, Pillay D, Dunn DT; UK HIV Drug Resistance Database.; (UKHDRD) and the UK Collaborative HIV Cohort (UK CHIC) Study Steering Committees.; UK HIV Drug Resistance Database (UKHDRD) and the UK Collaborative HIV Cohort (UK CHIC) Study Steering Committees..

J Antimicrob Chemother. 2016 Dec;71(12):3487-3494. Epub 2016 Sep 28.

5.

No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom.

White E, Smit E, Churchill D, Collins S, Booth C, Tostevin A, Sabin C, Pillay D, Dunn DT; UK HIV Drug Resistance Database and UK Collaborative HIV Cohort Study..

J Infect Dis. 2016 Nov 1;214(9):1302-1308. Epub 2016 May 24.

6.

Recent trends and patterns in HIV-1 transmitted drug resistance in the United Kingdom.

Tostevin A, White E, Dunn D, Croxford S, Delpech V, Williams I, Asboe D, Pozniak A, Churchill D, Geretti AM, Pillay D, Sabin C, Leigh-Brown A, Smit E; UK HIV Drug Resistance Database..

HIV Med. 2017 Mar;18(3):204-213. doi: 10.1111/hiv.12414. Epub 2016 Aug 1.

7.

Reconstructing the HIV-1 CRF02_AG and CRF06_cpx epidemics in Burkina Faso and West Africa using early samples.

Yebra G, Kalish ML, Leigh Brown AJ.

Infect Genet Evol. 2016 Dec;46:209-218. doi: 10.1016/j.meegid.2016.03.038. Epub 2016 Apr 6.

PMID:
27063411
8.

Transmission of Non-B HIV Subtypes in the United Kingdom Is Increasingly Driven by Large Non-Heterosexual Transmission Clusters.

Ragonnet-Cronin M, Lycett SJ, Hodcroft EB, Hué S, Fearnhill E, Brown AE, Delpech V, Dunn D, Leigh Brown AJ; United Kingdom HIV Drug Resistance Database..

J Infect Dis. 2016 May 1;213(9):1410-8. doi: 10.1093/infdis/jiv758. Epub 2015 Dec 23.

9.

Virological failure and development of new resistance mutations according to CD4 count at combination antiretroviral therapy initiation.

Jose S, Quinn K, Dunn D, Cox A, Sabin C, Fidler S; UK CHIC and UK HDRD Steering Committees..

HIV Med. 2016 May;17(5):368-72. doi: 10.1111/hiv.12302. Epub 2015 Aug 25.

10.

Evidence of Self-Sustaining Drug Resistant HIV-1 Lineages Among Untreated Patients in the United Kingdom.

Mbisa JL, Fearnhill E, Dunn DT, Pillay D, Asboe D, Cane PA; UK HIV Drug Resistance Database..

Clin Infect Dis. 2015 Sep 1;61(5):829-36. doi: 10.1093/cid/civ393. Epub 2015 May 19.

PMID:
25991470
11.

PANGEA-HIV: phylogenetics for generalised epidemics in Africa.

Pillay D, Herbeck J, Cohen MS, de Oliveira T, Fraser C, Ratmann O, Brown AL, Kellam P; PANGEA-HIV Consortium..

Lancet Infect Dis. 2015 Mar;15(3):259-61. doi: 10.1016/S1473-3099(15)70036-8. No abstract available.

12.

Determining the phylogenetic and phylogeographic origin of highly pathogenic avian influenza (H7N3) in Mexico.

Lu L, Lycett SJ, Leigh Brown AJ.

PLoS One. 2014 Sep 16;9(9):e107330. doi: 10.1371/journal.pone.0107330. eCollection 2014.

13.

Phylogenetic analyses reveal HIV-1 infections between men misclassified as heterosexual transmissions.

Hué S, Brown AE, Ragonnet-Cronin M, Lycett SJ, Dunn DT, Fearnhill E, Dolling DI, Pozniak A, Pillay D, Delpech VC, Leigh Brown AJ; UK Collaboration on HIV Drug Resistance and the Collaborative HIV, Anti-HIV Drug Resistance Network (CHAIN)..

AIDS. 2014 Aug 24;28(13):1967-75. doi: 10.1097/QAD.0000000000000383.

PMID:
24991999
14.

The contribution of viral genotype to plasma viral set-point in HIV infection.

Hodcroft E, Hadfield JD, Fearnhill E, Phillips A, Dunn D, O'Shea S, Pillay D, Leigh Brown AJ; UK HIV Drug Resistance Database.; UK CHIC Study..

PLoS Pathog. 2014 May 1;10(5):e1004112. doi: 10.1371/journal.ppat.1004112. eCollection 2014 May.

15.

Dynamics of the emergence and establishment of a newly dominant genotype of Japanese encephalitis virus throughout Asia.

Schuh AJ, Ward MJ, Leigh Brown AJ, Barrett AD.

J Virol. 2014 Apr;88(8):4522-32. doi: 10.1128/JVI.02686-13. Epub 2014 Feb 5.

16.

Reassortment patterns of avian influenza virus internal segments among different subtypes.

Lu L, Lycett SJ, Leigh Brown AJ.

BMC Evol Biol. 2014 Jan 24;14:16. doi: 10.1186/1471-2148-14-16.

17.

Novel HIV-1 recombinants spreading across multiple risk groups in the United Kingdom: the identification and phylogeography of Circulating Recombinant Form (CRF) 50_A1D.

Foster GM, Ambrose JC, Hué S, Delpech VC, Fearnhill E, Abecasis AB, Leigh Brown AJ, Geretti AM; UK HIV Drug Resistance Database..

PLoS One. 2014 Jan 15;9(1):e83337. doi: 10.1371/journal.pone.0083337. eCollection 2014.

18.

The increasing genetic diversity of HIV-1 in the UK, 2002-2010.

UK Collaborative Group on HIV Drug Resistance..

AIDS. 2014 Mar 13;28(5):773-80. doi: 10.1097/QAD.0000000000000119.

19.

The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adults.

Mackie NE, Dunn DT, Dolling D, Garvey L, Harrison L, Fearnhill E, Tilston P, Sabin C, Geretti AM; UK HIV Drug Resistance Database.; UK CHIC study..

AIDS. 2013 Sep 10;27(14):2245-53. doi: 10.1097/QAD.0b013e3283636179.

PMID:
24157905
20.

The global transmission network of HIV-1.

Wertheim JO, Leigh Brown AJ, Hepler NL, Mehta SR, Richman DD, Smith DM, Kosakovsky Pond SL.

J Infect Dis. 2014 Jan 15;209(2):304-13. doi: 10.1093/infdis/jit524. Epub 2013 Oct 22.

Supplemental Content

Loading ...
Support Center